Lung cancer with focal lymphocytic interstitial pneumonia

Shuji Bandoh1, Jiro Fujita, Reiji Haba

  • 1First Department of Internal Medicine, Kagawa Medical University, Kita-gun, Kagawa.

Insights

This study reports the first observed association between lung cancer and lymphocytic interstitial pneumonia (LIP). Focal LIP may represent a local immune response to lung cancer.

Area of Science:

  • Pulmonology
  • Oncology
  • Immunology

Background:

  • Lung cancer diagnosis and staging are critical in patient management.
  • Lymphocytic interstitial pneumonia (LIP) is a rare interstitial lung disease.
  • The relationship between autoimmune conditions and lung cancer is an area of ongoing research.

Observation:

  • A 65-year-old man presented with a stage IA lung adenocarcinoma.
  • The resected tumor showed papillary adenocarcinoma with significant lymphocytic infiltration.
  • This infiltration was consistent with focal lymphocytic interstitial pneumonia (LIP), without systemic autoimmune disease.

Findings:

  • Immunohistochemistry revealed CD8-positive T-cells as the predominant infiltrating lymphocytes.
  • These CD8+ T-cells were present in both the tumor and enlarged alveolar septa.
  • This is the first documented case linking lung cancer and LIP.

Implications:

  • The focal LIP observed in this case may indicate a local immune response to the lung cancer.
  • Further research is warranted to explore the potential immunomodulatory role of LIP in lung cancer development.
  • This finding could open new avenues for understanding lung cancer pathogenesis and immune interactions.